Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 178 163 | déclaré | 29 déc. 2025 | tx 70+980 709−353 773 |
| NOVEN PHARMACEUTICALS INC | 0 | déclaré | 27 août 2009 | tx 14+65 279−72 779 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 334 | — | |
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 334 | 0.00 USD | deriv |
| 08 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | — | |
| 08 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 947 | — | |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 18 115 | 0.00 USD | deriv |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 5 468 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 947 | 0.00 USD | deriv |
| 14 févr. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | — | |
| 14 févr. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | deriv |
| 08 janv. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50 000 | 2.24 USD | |
| 08 janv. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50 000 | 0.00 USD | deriv |
| 27 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 333 | — | |
| 27 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 333 | 0.00 USD | deriv |
| 09 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | — | |
| 09 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | 0.00 USD | deriv |
| 21 nov. 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 2 841 | 0.00 USD | deriv |
| 21 nov. 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 23 248 | 0.00 USD | deriv |
| 15 févr. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | — | |
| 15 févr. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | deriv |
| 05 févr. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 40 000 | 4.01 USD | |
| 05 févr. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 40 000 | 0.00 USD | deriv |
| 27 déc. 2023 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 333 | — | |
| 27 déc. 2023 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 333 | 0.00 USD | deriv |
| 08 déc. 2023 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 29 524 | 0.00 USD | deriv |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 30 mai 2018.